Jove
Visualize
Contact Us

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

615
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
615
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

251
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
251
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

3.2K
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
3.2K
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

279
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
279
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

114
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
114
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

184
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
184

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enzyme replacement therapy for late-onset Pompe disease.

The Cochrane database of systematic reviews·2023
Same author

Characterising a homozygous two-exon deletion in UQCRH: comparing human and mouse phenotypes.

EMBO molecular medicine·2021
Same author

Recombinant growth hormone therapy for X-linked hypophosphatemia in children.

The Cochrane database of systematic reviews·2021
Same author

Rituximab for eradicating inhibitors in people with acquired haemophilia A.

The Cochrane database of systematic reviews·2021
Same author

Tyrosine supplementation for phenylketonuria.

The Cochrane database of systematic reviews·2021
Same author

Dietary Management, Clinical Status and Outcome of Patients with Citrin Deficiency in the UK.

Nutrients·2020
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Dec 14, 2025

A Treatment Package without Escape Extinction to Address Food Selectivity
04:23

A Treatment Package without Escape Extinction to Address Food Selectivity

Published on: August 21, 2015

11.9K

Dietary interventions for phenylketonuria.

Elisabeth Jameson1, Tracey Remmington2

  • 1Willink Biochemical Genetics Unit, Manchester Centre for Genomic Medicine, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.

The Cochrane Database of Systematic Reviews
|July 17, 2020
PubMed
Summary
This summary is machine-generated.

Phenylketonuria (PKU) management involves a strict low-phenylalanine diet to prevent cognitive impairment. While effective, lifelong adherence is debated; evidence suggests continuing the diet improves intelligence quotient (IQ).

More Related Videos

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
14:39

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults

Published on: April 22, 2022

4.2K
Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet
07:05

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet

Published on: January 3, 2017

9.2K

Related Experiment Videos

Last Updated: Dec 14, 2025

A Treatment Package without Escape Extinction to Address Food Selectivity
04:23

A Treatment Package without Escape Extinction to Address Food Selectivity

Published on: August 21, 2015

11.9K
Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
14:39

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults

Published on: April 22, 2022

4.2K
Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet
07:05

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet

Published on: January 3, 2017

9.2K

Area of Science:

  • Metabolic Disorders
  • Genetics
  • Neuroscience

Background:

  • Phenylketonuria (PKU) is an inherited metabolic disorder requiring lifelong dietary management.
  • Early dietary intervention with phenylalanine restriction is crucial for preventing intellectual disability.
  • The optimal duration and restrictiveness of the PKU diet remain subjects of ongoing debate.

Purpose of the Study:

  • To evaluate the efficacy of early-initiated low-phenylalanine diets in individuals with PKU.
  • To assess the impact of diet relaxation or discontinuation on cognitive function, neuropsychological outcomes, and quality of life.

Main Methods:

  • Systematic review of randomized and quasi-randomized controlled trials.
  • Searched multiple databases including the Cochrane Cystic Fibrosis and Genetic Disorders Group Trials Register.
  • Data extraction and quality assessment performed by two independent authors.

Main Results:

  • Low-phenylalanine diet significantly reduced blood phenylalanine levels compared to less restricted diets.
  • A single study indicated a higher intelligence quotient (IQ) in participants who continued the diet.
  • Limited randomized controlled trials (RCTs) were available, with few significant differences found between groups.

Conclusions:

  • Non-randomized studies strongly support early low-phenylalanine diet initiation for PKU to improve outcomes.
  • An RCT comparing diet versus no diet from diagnosis is considered unethical.
  • Further RCTs are needed to determine optimal phenylalanine levels and timing for diet relaxation, though none are anticipated.